SBS 15th Annual Conference & Exhibition Lille, France April 26-30, 2009 Podium Presentation Abstracts Titles In Alphabetical Order Beginning with: C - H Case Studies in Fragment-Based Drug Discovery Steven Howard, Astex Therapeutics, UK Complex Allosteric Functioning of Metabotropic Glutamate Receptors: A Chance for New Drug Opportunities Jean-Philippe Pin, INSERM - Université de Montpellier, France Computational and in vitro ADME Approaches in Drug Discovery Nigel Waters, Novartis, UK Discovering New Antimalarial Drugs: Medicines for Malaria Venture's Vision Didier LeRoy, Medicines for Malaria Venture, Switzerland Do Technologies Improve Innovation and Productivity in the Biopharmaceutical Industry? Frank L. Douglas, Ewing Marion Kauffman Foundation & Partner Pure Tech Ventures, USA Drug Repositioning Using Literature Analytics: The Biovista Platform Andreas Persidis, Biovista, Greece Drug-induced Mitochrondiral Dysfunction: A Novel Mechanism for Idiosyncratic Toxicity James Dykens, Pfizer, UK Engineering Cells to Death James A. Wells, University of California, San Francisco, USA Fragment-based Drug Discovery of Novel MK2 Inhibitors Thomas Hesterkamp, Evotec Ltd., UK G protein-independent Assays for Screening of Seven-transmembrane Receptors Guido Zaman , Schering-Plough Research Institute, Netherlands G protein-independent Receptor Signalling: New Biological/Therapeutic Targets? Marc Caron, Duke University Medical Center, USA High-Throughput Cell Purification of Primary Cells, Human Embryonic Stem Cells and Accelerated Cell Line Generation Gary Bright, Cyntellect, Inc., USA High-throughput Characterization of Proteins from Microtiter Plates to Microfluidics Paul Dalby, University College London, UK HTS of Peptide Pharmaceucticals Alexander Chenchik, Cellecta, Inc., USA Go Back to the Start Page List talks by Track List talks by Day and Session List talks by Presenting Author List talks in Alphabetical Order